Abstract
Our previous studies demonstrated that silver nanoparticles (AgNPs) could be used as a potential radio-sensitizer for glioma radiotherapy enhancement, which, however, is restricted by autophagy elicitation. As one of the most promising drug-delivery carriers, mesoporous silica nanospheres (MSNs) have made great contributions to the developments of biomedicine due to their excellent drug loading performance, inherent biocompatibility, and tunable pore size. Herein, we designed autophagy inhibitor (3-methyladenine)-loaded AgNPs-cored MSNs, which exhibited excellent synergistic anticancer efficacy in vitro and in vivo. Besides, it was also confirmed that by inhibition of autophagy, the outcome of radiotherapy can be further enhanced. Moreover, we also explored the enhancing mechanisms from the perspective of the nuclear transcription factor Nrf2, including autophagy inhibition-related enhancement of radiation induced oxidative stress injury and the interaction of Nrf2 with autophagy. This study provided a vision of utilizing AgNPs as a potential radiosensitizer in combination with autophagy inhibitor and proposed a feasible strategy for its translation into the clinic.
摘要
先前研究表明, 银纳米颗粒可作为潜在的胶质瘤放疗的增敏剂, 但这一作用受到自噬的限制. 作为最有前途的药物递送载体之一, 介孔二氧化硅纳米球由于其优异的药物负载性能、 固有的生物相容性和可调节的孔径, 对生物医学的发展做出了巨大贡献. 在此, 我们设计了一种负载自噬抑制剂3-甲基腺嘌呤的纳米银核介孔二氧化硅纳米球, 其在体外和体内均表现出优异的协同抗癌作用. 并且证实了抑制自噬可以进一步改善胶质瘤放疗的效果. 此外, 还从与氧化应激相关的核转录因子Nrf2的角度探讨了可能的机制, 包括自噬抑制增强辐射诱导的氧化应激损伤以及Nrf2与自噬的相互作用. 这项研究为将纳米银作为与自噬抑制剂结合用于胶质瘤放射增敏提供了一个愿景, 并为其临床转化提供了一种可行的策略.
References
Björkblom B, Wibom C, Eriksson M, et al. Distinct metabolic hallmarks of WHO classified adult glioma subtypes. Neuro-Oncology, 2022, 24: 1454–1468
Ostrom QT, Cote DJ, Ascha M, et al. Adult glioma incidence and survival by race or ethnicity in the united states from 2000 to 2014. JAMA Oncol, 2018, 4: 1254
Fleischmann DF, Schön R, Corradini S, et al. Multifocal high-grade glioma radiotherapy safety and efficacy. Radiat Oncol, 2021, 16: 165
Griveau A, Seano G, Shelton SJ, et al. A glial signature and Wnt7 signaling regulate glioma-vascular interactions and tumor microenvironment. Cancer Cell, 2018, 33: 874–889.e7
Wang Z, Zhan M, Hu X. Pulsed laser excited photoacoustic effect for disease diagnosis and therapy. Chem Eur J, 2022, 28
Zhao J, Liu P, Ma J, et al. Enhancement of radiosensitization by silver nanoparticles functionalized with polyethylene glycol and aptamer As1411 for glioma irradiation therapy. IJN, 2019, Volume 14: 9483–9496
Yang X, Gao L, Guo Q, et al. Nanomaterials for radiotherapeutics-based multimodal synergistic cancer therapy. Nano Res, 2020, 13: 2579–2594
Chaloupka K, Malam Y, Seifalian AM. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol, 2010, 28: 580–588
Chen X, Schluesener HJ. Nanosilver: A nanoproduct in medical application. Toxicol Lett, 2008, 176: 1–12
Liu PD, Jin H, Guo Z, et al. Silver nanoparticles outperform gold nanoparticles in radiosensitizing U251 cells in vitro and in an intracranial mouse model of glioma. IJN, 2016, Volume 11: 5003–5014
Hsin YH, Chen CF, Huang S, et al. The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett, 2008, 179: 130–139
Soumya RS, Hela PG. Nano silver based targeted drug delivery for treatment of cancer. Der Pharm Lettre, 2013, 5: 189–197
Rubinsztein DC, Mariño G, Kroemer G. Autophagy and aging. Cell, 2011, 146: 682–695
Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer, 2017, 17: 528–542
Mathew R, Karantza-Wadsworth V, White E. Role of autophagy in cancer. Nat Rev Cancer, 2007, 7: 961–967
Liu P, Huang Z, Chen Z, et al. Silver nanoparticles: A novel radiation sensitizer for glioma? Nanoscale, 2013, 5: 11829–11836
Wu H, Lin J, Liu P, et al. Is the autophagy a friend or foe in the silver nanoparticles associated radiotherapy for glioma? Biomaterials, 2015, 62: 47–57
Wu H, Lin J, Liu P, et al. Reactive oxygen species acts as executor in radiation enhancement and autophagy inducing by AgNPs. Biomaterials, 2016, 101: 1–9
Lin J, Huang Z, Wu H, et al. Inhibition of autophagy enhances the anticancer activity of silver nanoparticles. Autophagy, 2014, 10: 2006–2020
Lin J, Liu Y, Wu H, et al. Key role of TFEB nucleus translocation for silver nanoparticle-induced cytoprotective autophagy. Small, 2018, 14: 1703711
Zhu L, Guo D, Sun L, et al. Activation ofautophagy by elevated reactive oxygen species rather than released silver ions promotes cytotoxicity of polyvinylpyrrolidone-coated silver nanoparticles in hematopoietic cells. Nanoscale, 2017, 9: 5489–5498
Pan L, He Q, Liu J, et al. Nuclear-targeted drug delivery of TAT pep-tide-conjugated monodisperse mesoporous silica nanoparticles. J Am Chem Soc, 2012, 134: 5722–5725
Wan X, Liu T, Hu J, et al. Photo-degradable, protein-polyelectrolyte complex-coated, mesoporous silica nanoparticles for controlled co-release of protein and model drugs. Macromol Rapid Commun, 2013, 34: 341–347
Wu T, Ge Z, Liu S. Fabrication of thermoresponsive cross-linked poly-(N-isopropylacrylamide) nanocapsules and silver nanoparticle-embedded hybrid capsules with controlled shell thickness. Chem Mater, 2011, 23: 2370–2380
Tarn D, Ashley CE, Xue M, et al. Mesoporous silica nanoparticle nanocarriers: Biofunctionality and biocompatibility. Acc Chem Res, 2013, 46: 792–801
Li Z, Barnes JC, Bosoy A, et al. Mesoporous silica nanoparticles in biomedical applications. Chem Soc Rev, 2012, 41: 2590–2605
Manzano M, Vallet-Regí M. Mesoporous silica nanoparticles for drug delivery. Adv Funct Mater, 2020, 30: 1902634
Han L, Wei H, Tu B, et al. A facile one-pot synthesis of uniform core-shell silver nanoparticle@mesoporous silica nanospheres. Chem Commun, 2011, 47: 8536–8538
Wang Y, Ding X, Chen Y, et al. Antibiotic-loaded, silver core-embedded mesoporous silica nanovehicles as a synergistic antibacterial agent for the treatment of drug-resistant infections. Biomaterials, 2016, 101: 207–216
Zheng N, Liu P. Amine facilitates the synthesis of silica-supported ultrasmall bimetallic nanoparticles. Sci China Mater, 2018, 61: 1129–1131
Che S, Liu Z, Ohsuna T, et al. Synthesis and characterization of chiral mesoporous silica. Nature, 2004, 429: 281–284
Thomassen LCJ, Aerts A, Rabolli V, et al. Synthesis and characterization of stable monodisperse silica nanoparticle sols for in vitro cyto-toxicity testing. Langmuir, 2010, 26: 328–335
Jing M, Li Y, Wang M, et al. Photoresponsive PAMAM-assembled nanocarrier loaded with autophagy inhibitor for synergistic cancer therapy. Small, 2021, 17: 2102295
Zhang Y, Zhi Z, Jiang T, et al. Spherical mesoporous silica nano-particles for loading and release of the poorly water-soluble drug telmisartan. J Control Release, 2010, 145: 257–263
Huang S, Ma P’, Wei Y, et al. Controllable synthesis of hollow porous silica nanotubes/CuS nanoplatform for targeted chemo-photothermal therapy. Sci China Mater, 2020, 63: 864–875
El Yamani N, Mariussen E, Gromelski M, et al. Hazard identification of nanomaterials: In silico unraveling of descriptors for cytotoxicity and genotoxicity. Nano Today, 2022, 46: 101581
Chen X, Zhang M, Gan H, et al. A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma. Nat Commun, 2018, 9: 2949
Yang Y, Wang Q, Song L, et al. Uptake of magnetic nanoparticles for adipose-derived stem cells with multiple passage numbers. Sci China Mater, 2017, 60: 892–902
Wang G, Song W, Shen N, et al. Curcumin-encapsulated polymeric nanoparticles for metastatic osteosarcoma cells treatment. Sci China Mater, 2017, 60: 995–1007
Liu C, Sun S, Feng Q, et al. Arsenene nanodots with selective killing effects and their low-dose combination with β-elemene for cancer therapy. Adv Mater, 2021, 33: 2102054
Wang X, Zhong X, Li J, et al. Inorganic nanomaterials with rapid clearance for biomedical applications. Chem Soc Rev, 2021, 50: 8669–8742
Mukha A, Kahya U, Dubrovska A. Targeting glutamine metabolism and autophagy: The combination for prostate cancer radiosensitization. Autophagy, 2021, 17: 3879–3881
Vera-Ramirez L, Vodnala SK, Nini R, et al. Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence. Nat Commun, 2018, 9: 1–2
Chen Q, He S, Zhang F, et al. A versatile Pt-Ce6 nanoplatform as catalase nanozyme and NIR-II photothermal agent for enhanced PDT/PTT tumor therapy. Sci China Mater, 2021, 64: 510–530
Xia H, Green DR, Zou W. Autophagy in tumour immunity and therapy. Nat Rev Cancer, 2021, 21: 281–297
Bourdenx M, Martín-Segura A, Scrivo A, et al. Chaperone-mediated autophagy prevents collapse of the neuronal metastable proteome. Cell, 2021, 184: 2696–2714.e25
Shi J, Wang D, Ma Y, et al. Photoactivated self-disassembly of multifunctional DNA nanoflower enables amplified autophagy suppression for low-dose photodynamic therapy. Small, 2021, 17: 2104722
Clement S, Campbell JM, Deng W, et al. Mechanisms for tuning engineered nanomaterials to enhance radiation therapy of cancer. Adv Sci, 2020, 7: 2003584
Maremonti E, Eide DM, Rossbach LM, et al. In vivo assessment of reactive oxygen species production and oxidative stress effects induced by chronic exposure to gamma radiation in Caenorhabditis elegans. Free Radical Biol Med, 2020, 152: 583–596
Pisoschi AM, Pop A, Iordache F, et al. Oxidative stress mitigation by antioxidants—An overview on their chemistry and influences on health status. Eur J Medicinal Chem, 2021, 209: 112891
Liu Z, Tan H, Zhang X, et al. Enhancement of radiotherapy efficacy by silver nanoparticles in hypoxic glioma cells. Artif Cells Nanomed Bio-technol, 2018, 46: 922–930
Li Y, Yan D, Fu F, et al. Composite core-shell microparticles from microfluidics for synergistic drug delivery. Sci China Mater, 2017, 60: 543–553
Toulany M. Targeting DNA double-strand break repair pathways to improve radiotherapy response. Genes, 2019, 10: 25
Li H, Yang Y, Hong W, et al. Applications of genome editing technology in the targeted therapy of human diseases: Mechanisms, advances and prospects. Sig Transduct Target Ther, 2020, 5: 1–27
Singh I, Ozturk N, Cordero J, et al. High mobility group proteinmediated transcription requires DNA damage marker γ-H2AX. Cell Res, 2015, 25: 837–850
Goutas A, Syrrou C, Papathanasiou I, et al. The autophagic response to oxidative stress in osteoarthritic chondrocytes is deregulated. Free Radical Biol Med, 2018, 126: 122–132
Rojo de la Vega M, Chapman E, Zhang DD. Nrf2 and the hallmarks of cancer. Cancer Cell, 2018, 34: 21–43
Tonelli C, Chio IIC, Tuveson DA. Transcriptional regulation by Nrf2. Antioxid Redox Signal, 2018, 29: 1727–1745
Lu J, Wang R, Shen L, et al. Enabling topical and long-term anti-radical properties for percutaneous coronary intervention-related complications by incorporating TEMPOL into electrospun nanofibers. Sci China Mater, 2021, 64: 769–782
McDonald JT, Kim K, Norris AJ, et al. Ionizing radiation activates the Nrf2 antioxidant response. Cancer Res, 2010, 70: 8886–8895
Sun X, Yang Y, Shi J, et al. NOX4- and Nrf2-mediated oxidative stress induced by silver nanoparticles in vascular endothelial cells. J Appl Toxicol, 2017, 37: 1428–1437
Ichimura Y, Waguri S, Sou Y, et al. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol Cell, 2013, 51: 618–631
Walker A, Singh A, Tully E, et al. Nrf2 signaling and autophagy are complementary in protecting breast cancer cells during glucose deprivation. Free Radical Biol Med, 2018, 120: 407–413
Towers CG, Fitzwalter BE, Regan D, et al. Cancer cells upregulate Nrf2 signaling to adapt to autophagy inhibition. Dev Cell, 2019, 50: 690–703.e6
Lv H, Yang H, Wang Z, et al. Nrf2 signaling and autophagy are complementary in protecting lipopolysaccharide/d-galactosamine-induced acute liver injury by licochalcone A. Cell Death Dis, 2019, 10: 313
Tao S, Zhang H, Xue L, et al. Vitamin D protects against particles-caused lung injury through induction of autophagy in an Nrf2-dependent manner. Environ Toxicol, 2019, 34: 594–609
Tao S, Wang S, Moghaddam SJ, et al. Oncogenic KRAS confers chemoresistance by upregulating Nrf2. Cancer Res, 2014, 74: 7430–7441
Guan L, Zhang L, Gong Z, et al. FoxO3 inactivation promotes human cholangiocarcinoma tumorigenesis and chemoresistance through Keap1-Nrf2 signaling. Hepatology, 2016, 63: 1914–1927
Acknowledgements
We highly appreciate financial supports from the National Key Research and Development Program of China (2019YFA0210103 and 2017YFA0104302), the National Natural Science Foundation of China (81901873, 51832001, and 81971701), the National Key Laboratory of Science and Technology on Strong Electromagnetic Environment Simulation and Protection (6142205190402), the Natural Science Foundation of Jiangsu Province (BK20201352), and the Program of Jiangsu Specially Appointed Professor.
Author information
Authors and Affiliations
Contributions
Author contributions Wu H designed and performed the experiments and wrote the paper; Gu N proposed the concept and supervised this study. All authors contributed to the general discussion and revision of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest The authors declare that they have no conflict of interest.
Additional information
Supplementary information Supporting data are available in the online version of the paper.
Hao Wu received his PhD degree from Southeast University in 2016. He is now a lecturer at the School of Biomedical Engineering and Informatics, Nanjing Medical University. His research focuses on biological effects of nanomaterials and electromagnetic fields.
Ning Gu was born in 1964. He received his PhD degree in biomedical engineering from the Department of Biomedical Engineering, Southeast University, Nanjing, China, in 1996. Currently he is an academician of the Chinese Academy of Sciences, Changjiang Scholar Professor and NSFC Outstanding Young Investigator Fund Winner at the School of Medical, Nanjing University. His research interests include biomaterials, nanobiology, medical imaging, and advanced instrument development.
Rights and permissions
About this article
Cite this article
Wu, H., Yuan, Y., Kang, S. et al. Autophagy inhibitor-loaded mesoporous AgNPs@SiO2 nanoplatform for synergistically enhanced glioma radiotherapy. Sci. China Mater. 66, 2902–2912 (2023). https://doi.org/10.1007/s40843-022-2395-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40843-022-2395-y